Skip to Content

OvaScience, Inc.

Company NameOvaScience, Inc.
Stock SymbolOVAS

The Firm announces an investigation on behalf of investors who purchased OvaScience, Inc. (“OvaScience” or the “Company”) (Nasdaq: OVAS) securities pursuant or traceable to the Company’s January 8, 2015 Offering and Registration Statement. Investors who have suffered losses on their investment in OvaScience securities are encouraged to contact GPM at 310-201-9150 to discuss their legal rights.

The investigation focuses on whether OvaScience made materially untrue and misleading statements and omitted material information because the Company failed to disclose that OvaScience's AUGMENT procedure did not achieve a significant success rate of clinical pregnancies compared to previous rates achieved without the Company's AUGMENT procedure. Investors have suffered damages following the sharp decline of the Company’s common stock from an offering price of $50 per share, to a recent close on January 21, 2015 of $8.74 per share.

If you purchased OvaScience securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224 or by email to

Submit Your Information

If you suffered a loss on your OvaScience, Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.

An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.

Shares Purchased

Number of SharesBuy DatePrice Per ShareAdd

Shares Sold

Number of SharesSell DatePrice Per ShareAdd